Virpax Pharmaceuticals



U.S. Food and Drug Administration

FDA Takes Steps Aimed at Fostering Development of Non-Addictive Alternatives to Opioids for Acute Pain Management

WASHINGTON, D.C. — The U.S. Food and Drug Administration recently took new steps aimed at fostering the development of non-addictive alternatives to opioids to manage acute pain and decreasing exposure …

FDA Takes Steps Aimed at Fostering Development of Non-Addictive Alternatives to Opioids for Acute Pain Management Read More